Total energy expenditure assessed by 24-h whole-room indirect calorimeter in patients with colorectal cancer: baseline findings from the PRIMe study.

body composition cancer energy expenditure energy requirements whole-body indirect calorimetry whole-room indirect calorimetry

Journal

The American journal of clinical nutrition
ISSN: 1938-3207
Titre abrégé: Am J Clin Nutr
Pays: United States
ID NLM: 0376027

Informations de publication

Date de publication:
08 2023
Historique:
received: 03 01 2023
revised: 19 05 2023
accepted: 05 06 2023
medline: 7 8 2023
pubmed: 9 6 2023
entrez: 8 6 2023
Statut: ppublish

Résumé

Total energy expenditure (TEE) determines energy requirements, but objective data in patients with cancer are limited. We aimed to characterize TEE, investigate its predictors, and compare TEE with cancer-specific predicted energy requirements. This cross-sectional analysis included patients with stages II-IV colorectal cancer from the Protein Recommendation to Increase Muscle (PRIMe) trial. TEE was assessed by 24-h stay in a whole-room indirect calorimeter before dietary intervention and compared with cancer-specific predicted energy requirements (25-30 kcal/kg). Generalized linear models, paired-samples t tests, and Pearson correlation were applied. Thirty-one patients (56 ± 10 y; body mass index [BMI]: 27.9 ± 5.5 kg/m This is the largest study to assess TEE of patients with cancer using whole-room indirect calorimeter and highlights the need for improved assessment of energy requirements in this population. Energy requirements predicted using 30 kcal/kg overestimated TEE by 1.44 times in a controlled sedentary environment and TEE was outside of the predicted requirement range for most. Special considerations are warranted when determining TEE of patients with colorectal cancer, such as BMI, body composition, and tumor location. This is a baseline cross-sectional analysis from a clinical trial registered at clinicaltrials.gov as NCT02788955 (https://clinicaltrials.gov/ct2/show/NCT02788955).

Sections du résumé

BACKGROUND
Total energy expenditure (TEE) determines energy requirements, but objective data in patients with cancer are limited.
OBJECTIVES
We aimed to characterize TEE, investigate its predictors, and compare TEE with cancer-specific predicted energy requirements.
METHODS
This cross-sectional analysis included patients with stages II-IV colorectal cancer from the Protein Recommendation to Increase Muscle (PRIMe) trial. TEE was assessed by 24-h stay in a whole-room indirect calorimeter before dietary intervention and compared with cancer-specific predicted energy requirements (25-30 kcal/kg). Generalized linear models, paired-samples t tests, and Pearson correlation were applied.
RESULTS
Thirty-one patients (56 ± 10 y; body mass index [BMI]: 27.9 ± 5.5 kg/m
CONCLUSIONS
This is the largest study to assess TEE of patients with cancer using whole-room indirect calorimeter and highlights the need for improved assessment of energy requirements in this population. Energy requirements predicted using 30 kcal/kg overestimated TEE by 1.44 times in a controlled sedentary environment and TEE was outside of the predicted requirement range for most. Special considerations are warranted when determining TEE of patients with colorectal cancer, such as BMI, body composition, and tumor location. This is a baseline cross-sectional analysis from a clinical trial registered at clinicaltrials.gov as NCT02788955 (https://clinicaltrials.gov/ct2/show/NCT02788955).

Identifiants

pubmed: 37290740
pii: S0002-9165(23)65964-7
doi: 10.1016/j.ajcnut.2023.06.002
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT02788955']

Types de publication

Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

422-432

Informations de copyright

Copyright © 2023 American Society for Nutrition. Published by Elsevier Inc. All rights reserved.

Auteurs

Katherine L Ford (KL)

Department of Agricultural, Food & Nutritional Science, University of Alberta, Edmonton, Canada.

Claude Pichard (C)

Clinical Nutrition, Geneva University Hospital, Geneva, Switzerland.

Michael B Sawyer (MB)

Department of Oncology, University of Alberta, Edmonton, Canada.

Claire F Trottier (CF)

Department of Agricultural, Food & Nutritional Science, University of Alberta, Edmonton, Canada.

Ilana Roitman Disi (IR)

Department of Agricultural, Food & Nutritional Science, University of Alberta, Edmonton, Canada; Department of Anesthesia, University of Sao Paulo, Sao Paulo, Brazil.

Sarah A Purcell (SA)

Department of Agricultural, Food & Nutritional Science, University of Alberta, Edmonton, Canada; Department of Medicine, University of British Columbia, Vancouver, Canada; Department of Biology, University of British Columbia Okanagan, Kelowna, Canada.

Sunita Ghosh (S)

Department of Oncology, University of Alberta, Edmonton, Canada.

Mario Siervo (M)

School of Population Health, Curtin University, Perth, Australia; Curtin Dementia Centre of Excellence, enAble Institute, Curtin University, Perth, Australia.

Nicolaas Ep Deutz (NE)

Center for Translational Research in Aging and Longevity, Texas A&M University, College Station, United States.

Carla M Prado (CM)

Department of Agricultural, Food & Nutritional Science, University of Alberta, Edmonton, Canada. Electronic address: carla.prado@ualberta.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH